These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1606917)

  • 1. In vivo effect of pituitary adenylate cyclase activating polypeptide 38 (PACAP 38) on the secretion of luteinizing hormone (LH) in male rats.
    Osuga Y; Mitsuhashi N; Mizuno M
    Endocrinol Jpn; 1992 Feb; 39(1):153-6. PubMed ID: 1606917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe.
    Sawangjaroen K; Curlewis JD
    J Neuroendocrinol; 1994 Oct; 6(5):549-55. PubMed ID: 7827625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.
    Sawangjaroen K; Anderson ST; Curlewis JD
    J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
    Huang SK; Pan JT
    Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats.
    Hart GR; Gowing H; Burrin JM
    J Endocrinol; 1992 Jul; 134(1):33-41. PubMed ID: 1380057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
    Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain.
    Li S; Grinevich V; Fournier A; Pelletier G
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):157-62. PubMed ID: 8883947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.
    Mungan Z; Ertan A; Hammer RA; Arimura A
    Peptides; 1991; 12(3):559-62. PubMed ID: 1717954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks.
    Tachibana T; Saito S; Tomonaga S; Takagi T; Saito ES; Boswell T; Furuse M
    Neurosci Lett; 2003 Mar; 339(3):203-6. PubMed ID: 12633888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulatory effect of pituitary adenylate cyclase activating polypeptide (PACAP) on LH release from rat pituitary cells in vitro does not involve calcium mobilization.
    Perrin D; Söling HD; Wuttke W; Jarry H
    Exp Clin Endocrinol; 1993; 101(5):290-6. PubMed ID: 8299705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line.
    Schomerus E; Poch A; Bunting R; Mason WT; McArdle CA
    Endocrinology; 1994 Jan; 134(1):315-23. PubMed ID: 7903932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.
    Murase T; Kondo K; Otake K; Oiso Y
    Neuroendocrinology; 1993 Jun; 57(6):1092-6. PubMed ID: 7901784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide directly stimulates LH and FSH secretion by human pituitary gonadotrophinomas.
    Petersen B; Buchfelder M; Fahlbusch R; Adams EF
    Exp Clin Endocrinol Diabetes; 1996; 104(3):250-5. PubMed ID: 8817243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.